KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer
| dc.contributor.author | Fornaro, L. | |
| dc.contributor.author | Shitara, K. | |
| dc.contributor.author | Bang, Y. J. | |
| dc.contributor.author | Di Bartolomeo, M. | |
| dc.contributor.author | Mandala, M. | |
| dc.contributor.author | Ryu, M. H. | |
| dc.contributor.author | Olesinski, T. | |
| dc.contributor.author | Caglevic, C. | |
| dc.contributor.author | Chung, H. | |
| dc.contributor.author | Muro, K. | |
| dc.contributor.author | Gokkurt, E. | |
| dc.contributor.author | Mansoor, W. | |
| dc.contributor.author | McDermott, R. | |
| dc.contributor.author | Schacham-Shmueli, E. | |
| dc.contributor.author | Chen, X. | |
| dc.contributor.author | Kang, S. P. | |
| dc.contributor.author | Mayo, C. | |
| dc.contributor.author | Ohtsu, A. | |
| dc.contributor.author | Fuchs, C. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.date.accessioned | 2021-03-05T07:28:26Z | |
| dc.date.available | 2021-03-05T07:28:26Z | |
| dc.identifier.citation | Shitara K., Ozguroglu M., Bang Y. J. , Di Bartolomeo M., Mandala M., Ryu M. H. , Fornaro L., Olesinski T., Caglevic C., Chung H., et al., "KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer", ESMO 20th World Congress on Gastrointestinal Cancer, Barcelona, İspanya, 20 - 23 Haziran 2018, cilt.29 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_93f8526b-9611-4d54-b218-2b19d63ca543 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/99703 | |
| dc.language.iso | eng | |
| dc.subject | İç Hastalıkları | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Onkoloji | |
| dc.title | KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer | |
| dc.type | Bildiri | |
| dc.contributor.department | National Cancer Center - Japan , , | |
| dc.identifier.volume | 29 | |
| dc.contributor.firstauthorID | 153860 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Bildiri [64839]